GlassScriptPhysician profile
Louis C Hebert
NPI 1891715413
$5,139.72
in general payments reported to CMS, 2019-2025
22 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $164 · 2021: $218 · 2022: $514 · 2023: $2,400 · 2024: $727 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,642 · Travel and Lodging: $1,182 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,641.51 |
| Travel and Lodging | $1,182.43 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,707.76 | 2023 | Fusion, Stealthstation S8 Platform |
| Glaxosmithkline, LLC. | $893.46 | 2021-2025 | Nucala |
| Optinose US, INC. | $649.35 | 2019-2025 | |
| Acclarent, INC | $376.69 | 2019-2024 | Acclarent Aera, Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $300.72 | 2022-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $281.20 | 2020-2025 | |
| Aerin Medical INC. | $208.81 | 2019-2025 | |
| Inspire Medical Systems, INC. | $151.74 | 2023-2025 | Inspire |
| Hikma Pharmaceuticals USA | $88.12 | 2023-2024 | Ryaltris |
| Integra Lifesciences Corporation | $74.02 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Amgen INC. | $61.88 | 2025 | Tezspire |
| Alk-Abello, INC | $58.14 | 2019 | |
| Atricure, INC. | $54.41 | 2023-2024 | |
| Baxter Healthcare | $46.59 | 2025 | Perclot, Floseal |
| Biom'Up France Sas | $43.51 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $34.47 | 2019-2024 | Immunocap |
| Stryker Corporation | $33.24 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $18.07 | 2023 | |
| Olympus America INC. | $15.88 | 2023 | Olympus |
| Cook Medical LLC | $15.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.91 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Hebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.